European Task Force on Atopic Dermatitis: position on vaccination of adult patients with atopic dermatitis against COVID-19 (SARS-CoV-2) being treated with systemic medication and biologics.

Authors :: Thyssen JP
Vestergaard C
Barbarot S
de Bruin-Weller MS
Bieber T
Taieb A
Seneschal J
Cork MJ
Paul C
Flohr C
Weidinger S
Trzeciak M
Werfel T
Heratizadeh A
Darsow U
Simon D
Torrelo A
Chernyshov PV
Stalder JF
Gelmetti C
Szalai Z
Svensson Å
von Kobyletzki LB
De Raeve L
Fölster-Holst R
Christen-Zaech S
Hijnen DJ
Gieler U
Gutermuth J
Bangert C
Spuls PI
Kunz B
Ring J
Wollenberg A
Deleuran M
Source :: Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2021 May; Vol. 35 (5), pp. e308-e311. Date of Electronic Publication: 2021 Mar 07.
Publication Year :: 2021

Subjects :: Adult
Humans
SARS-CoV-2
Vaccination
Biological Products
COVID-19
Dermatitis, Atopic drug therapy

Language :: English
ISSN :: 1468-3083
Volume :: 35
Issue :: 5
Database :: MEDLINE
Journal :: Journal of the European Academy of Dermatology and Venereology : JEADV
Publication Type :: Editorial & Opinion
Accession number :: 33587756
Full Text :: https://doi.org/10.1111/jdv.17167

Full Text Access

Tools